Effect of conversion from twice-daily to once-daily tacrolimus on glucose intolerance in stable kidney transplant recipients

Transplantation Proceedings

Volumn 44, Issue 1, 2012, Pages 118-120

  Tsuchiya, T ^a   Ishida, K ^a   Ito, S ^a   Deguchi, T ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; CLINICAL ARTICLE; CLINICAL EVALUATION; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GRAFT RECIPIENT; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT DURATION;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOSE INTOLERANCE; GRAFT REJECTION; GRAFT SURVIVAL; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; INSULIN-SECRETING CELLS; JAPAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84858725245     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.11.027     Document Type: Conference Paper

References (10)

1. A.C. Webster, R.C. Woodroffe, R.S. Taylor Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data BMJ 331 2005 810
2. J. Hjelmesaeth, A. Hartmann, T. Leivestad The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events Kidney Int 69 2006 588
3. F. Vincenti, S. Friman, E. Scheuermann Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus Am J Transplant 7 2007 1506
4. J.M. Boots, E.M. van Duijnhoven, M.H. Christiaans Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction J Am Soc Nephrol 13 2002 221
5. B.K. Kramer, B. Charpentier, L. Backman Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study Am J Transplant 10 2010 2632
6. M.R. First, W.E. Fitzsimmons Modified release tacrolimus Yonsei Med J 45 2004 1127
7. R. Alloway, S. Steinberg, K. Khalil et al. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients Transplantation 83 2007 1648
8. J.H. Nam, J.I. Mun, S.I. Kim beta-Cell dysfunction rather than insulin resistance is the main contributing factor for the development of postrenal transplantation diabetes mellitus Transplantation 71 2001 1417
9. T. Mitamura, A. Yamada, K. Hanaoka Effect of pharmacokinetic profile on the pancreatic toxicity and efficacy of tacrolimus in rats J Toxicol Sci 33 2008 575
10. C.B. Drachenberg, D.K. Klassen, M.R. Weir Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation Transplantation 68 1999 396